Tyrosine kinase inhibitors containing a zinc binding moiety

The invention relates to tyrosine kinase inhibitors, tyrosine and their related use in the treatment of diseases and disorders, containing a zinc-binding site. The derivatives can also serve as HDAC inhibitors.